|
|
Cancer Questions on the National Health Interview Survey
|
APC12017-001
|
$1,300,000
|
$195,000
|
N/A
|
National Center for Health Statistics
|
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
$4,772,724
|
N/A
|
(NCI)
|
|
|
Elucidation of cancer pathways and druggable targets using mouse models.
|
5U01CA084294-14
|
$753,359
|
$753,359
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Leadership Component in Chemoprevention: Mouse Models of Human Cancer Consortium
|
5U01CA141535-04
|
$371,833
|
$371,833
|
Abate-Shen, Cory
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Estrogen-ERbeta Axis In Disparity of Prostate Cancer
|
5U01CA149204-02
|
$299,290
|
$299,290
|
ABDEL-MAGEED, ASIM
|
TULANE UNIVERSITY OF LOUISIANA
|
|
|
Prostate Cancer Recurrence: models and mechanisms
|
1R01CA167966-01A1
|
$372,420
|
$372,420
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
Modeling Prostate Tumorigenesis
|
5R01CA094858-10
|
$233,032
|
$233,032
|
Abdulkadir, Sarki
|
VANDERBILT UNIVERSITY MED CTR
|
|
|
Redirecting T Cell Responses to Self/Tumor Antigens Using Enforced Costimulation
|
5R01CA109339-08
|
$298,295
|
$298,295
|
ADLER, ADAM
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities ( 1 of 3)
|
5U54CA163069-02
|
$1,328,312
|
$119,548
|
Adunyah, Samuel
|
MEHARRY MEDICAL COLLEGE
|
|
|
Prostate Cancer Prevention by Procyanidins in Grape Seed Extract
|
5R01CA091883-10
|
$322,493
|
$322,493
|
AGARWAL, CHAPLA
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Prostate Cancer Prevention and Treatment by Silibinin
|
5R01CA102514-09
|
$322,493
|
$322,493
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Clinical and Immunologic Evaluation of ProstAtak for Prostate Cancer
|
5R44CA124032-04
|
$1,917,582
|
$1,917,582
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
|
A Novel Therapeutic Approach for Primary and Metastatic Prostate Cancer
|
5R01CA150182-02
|
$293,483
|
$293,483
|
AHMED, KHALIL
|
UNIVERSITY OF MINNESOTA
|
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
$30,301
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
|
Targeting Endoplasmic Reticulum Stress Response for Cancer Therapy
|
7R01CA152312-02
|
$368,100
|
$184,050
|
AKTAS, BERTAL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
$145,113
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$270,685
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
SELECT and Prostate Cancer Prevention Trial (PCPT)
|
ZIA CP010221-10405
|
$244,799
|
$244,799
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
|
Comprehensive MRI, MRS and Molecular Analyses: Pten-based Prostate Cancer Models
|
5R01CA129003-06
|
$238,585
|
$238,585
|
ALBANESE, CHRISTOPHER
|
GEORGETOWN UNIVERSITY
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$4,500
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$8,631
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$237,229
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
$12,756
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Novel Molecular Therapies of Prostate Cancer
|
5P01CA140043-04
|
$1,216,100
|
$1,216,100
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
$251,665
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
|
Maryland Prostate Cancer Case-Control Study
|
ZIABC010499
|
$471,243
|
$471,243
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in African-American Men
|
ZIABC010624
|
$235,622
|
$235,622
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
The Molecular Profile of Prostate Tumors in Smokers
|
ZIABC010660
|
$58,905
|
$58,905
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIABC010886
|
$117,811
|
$117,811
|
Ambs, Stefan
|
CCR (NCI)
|
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIABC010030
|
$806,557
|
$40,328
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
|
LTG_Amundadottir
|
ZIA CP010201-10569
|
$601,906
|
$180,572
|
Amundadottir, Laufey
|
DCEG (NCI)
|
|
|
Predicting Prostate Cancer Aggressiveness
|
5U01CA151924-02
|
$574,247
|
$574,247
|
Anderson, Alexander
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Evaluation of antiangiogenic role of EM011, a novel tubulin-binding agent
|
5R00CA131489-05
|
$241,529
|
$120,765
|
Aneja, Ritu
|
GEORGIA STATE UNIVERSITY
|
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
$51,762
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
$236,236
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-09
|
$333,500
|
$66,700
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
Explosive Evolution Under Stress: The Driving Forces of Cancer Dynamics (Main)
|
5U54CA143803-04
|
$2,775,982
|
$666,236
|
Austin, Robert
|
PRINCETON UNIVERSITY
|
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
$49,679
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Comprehensive Tumor Microenvironment Based Prediction Models in Prostate Cancer
|
7R01CA140734-02
|
$315,400
|
$315,400
|
Ayala, Gustavo
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
|
|
Systemic delivery of chitosan/miRNA nanoparticles to prostate tumors
|
1R43CA156978-01A1
|
$299,999
|
$299,999
|
Bader, Andreas
|
MIRNA THERAPEUTICS, INC.
|
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-22
|
$536,603
|
$64,392
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
$137,123
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
$1,967
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Biorepository
|
3U24CA114748-07S1
|
$697,714
|
$69,771
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Psycho-sociocultural factors influencing cancer pain management in elderly adults
|
5K01CA131722-04
|
$140,069
|
$35,017
|
Baker, Tamara
|
UNIVERSITY OF SOUTH FLORIDA
|
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
$89,235
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-07
|
$1,125,491
|
$112,549
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Cancer-Associated, Interdependent Regulation of mTOR, AKT, and IKK/NF-kappaB
|
5R01CA075080-14
|
$295,242
|
$147,621
|
BALDWIN, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-14
|
$759,738
|
$151,948
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
|
Prevention of prostate cancer growth by a plant alkaloid
|
5R01CA131123-04
|
$308,958
|
$308,958
|
BANERJEE, PARTHA
|
GEORGETOWN UNIVERSITY
|
|
Total relevant funding to Prostate for this search: $265,094,495
|
